Advances in Treating Wet Age-Related Macular Degeneration with Dr. Jason Slakter Ohr Pharmaceutical

Published: Sept. 27, 2017, 10:03 p.m.

Vision impairment is a major factor contributing to loss of independent living for otherwise healthy seniors. Dr. Jason Slakter, M.D. leading expert ophthalmologist and CEO of Ohr Pharmaceutical, Inc. explains how wet age-related macular degeneration (wet-AMD) affects the eye, genetic and environmental factors for developing wet-AMD, and measures that can be taken to delay the onset of the disease. Dr. Slakter also talks about advances in treatments and the promise of a new eye drop that is being tested in clinical trials.

@OhrPharma

OhrPharmaceutical.com

#MacularDegeneration #AMD #wetAMD #EyeDisease

#Ophthalmology #medicine #eyeinfo